A nomogram for predicting hyperprogressive disease after immune checkpoint inhibitor treatment in lung cancer

BACKGROUND: Immune checkpoint inhibitor (ICI) therapy is an emerging type of treatment for lung cancer (LC). However, hyperprogressive disease (HPD) has been observed in patients treated with ICIs that lacks a prognostic prediction model. There is an urgent need for a simple and easily implementable...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Shuhui, Zhang, Yao, Zhou, Yan, Rong, Wenwen, Wang, Yue, Ling, Xuxinyi, Zhang, Lincheng, Li, Jingwen, Tomita, Yusuke, Watanabe, Satoshi, Nakada, Takeo, Seki, Nobuhiko, Hida, Toyoaki, Dermime, Said, Zhong, Runbo, Zhong, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073744/
https://www.ncbi.nlm.nih.gov/pubmed/35529793
http://dx.doi.org/10.21037/tlcr-22-171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073744/
https://www.ncbi.nlm.nih.gov/pubmed/35529793
http://dx.doi.org/10.21037/tlcr-22-171

Ejemplares similares